BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to All Ratios
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year EV/Core EBITDA History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/Core EBITDA(x) | -10.48 | -48.10 | -11.12 | -1.74 | -11.29 |
What is the latest EV/Core EBITDA ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | EV/Core EBITDA |
---|---|
Mar2023 | -10.48 |
Mar2022 | -48.10 |
Mar2021 | -11.12 |
Mar2020 | -1.74 |
Mar2019 | -11.29 |
How is EV/Core EBITDA of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | EV/Core EBITDA | % Change | |
---|---|---|---|
Mar2023 | -10.48 | Negative | |
Mar2022 | -48.1 | Negative | |
Mar2021 | -11.12 | Negative | |
Mar2020 | -1.74 | Negative | |
Mar2019 | -11.29 | - |
Other Financial Ratios of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹131.2 Cr | -5.6% | 2.8% | 26.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -5.6% |
2.8% |
26.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses